https://www.europeanpharmaceuticalreview.com/news/fda-sends-warning-letter-to-kvk-tech-manufacturing-facility/114192.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/adaflex-first-uk-licensed-melatonin-for-children-with-insomnia-and-adhd/175516.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-year-ahead-for-rna-therapeutic-development-and-manufacturing/240554.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/nice-makes-first-of-a-kind-recommendation-for-hearing-loss-drug/240759.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/hplc-method-demonstrates-value-for-quality-control-analysis-of-cardiovascular-drug/240768.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/roche-to-advance-potentially-best-in-class-antibody-drug-conjugate/242347.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-issues-first-recommendations-on-ai-for-drug-development/242364.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/hydrogel-encapsulation-unlocking-the-potential-of-cell-therapies-for-targeted-treatments/242454.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/embracing-green-innovation-in-life-sciences/242470.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/could-novel-gel-therapeutic-set-new-standard-of-care-in-oncology/242601.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/transitioning-to-digital-product-information-to-ensure-a-sustainable-future/242624.article 2026-04-01T09:23:50.960Z https://www.europeanpharmaceuticalreview.com/news/epi-rollout-backed-in-new-paper-by-pharmaceutical-bodies/242772.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazenecas-parp-inhibitor-newly-recommended-by-nice/242837.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/potential-blockbuster-drugs-to-watch-in-2025/242863.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/considerations-for-a-successful-tech-transfer-of-a-biologics-upstream-process/243226.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/gsk-acquisition-to-advance-potential-best-in-class-gi-tumour-treatment/243346.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/long-term-potential-revealed-for-novel-modifier-gene-therapy/243476.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/nsf-launches-compliance-unlocked-podcast-series/243554.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/ensuring-packaging-integrity-of-frozen-biopharmaceutical-products/243755.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-ibd-biologic-receives-expanded-us-approval/244064.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-guidance-to-aid-cost-effectiveness-analysis-of-new-drugs/244505.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/early-phase-atmp-clinical-trials-see-promising-growth/244782.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sustainability-and-technology-advancement-driving-spectroscopy-market/244910.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-innovative-monotherapy-for-treatment-resistant-depression/245004.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biologic-demonstrates-tremendous-potential-advance-in-atrial-fibrillation/245058.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/manda-outlook-for-pharma-in-2025/245077.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/benchtop-nmr-for-continuous-process-monitoring-in-pat/245187.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-canadian-investment-to-drive-randd-growth/245218.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/harnessing-industry-advancements-to-accelerate-upstream-process-development/245437.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/uk-biotech-on-positive-trajectory-says-bia/245461.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-analysis-asserts-survival-benefit-for-roche-breast-cancer-therapy/245571.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/enhancing-spectroscopy-analysis-with-machine-learning/245658.article 2026-04-23T17:11:12.913Z https://www.europeanpharmaceuticalreview.com/news/takeda-plans-2026-ceo-succession/245731.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/biosimilar-medicines-the-intersection-of-access-affordability-and-innovation/245839.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/uk-enhances-ilap-to-accelerate-access-to-innovative-medicines/245855.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-gene-therapy-for-severe-sickle-cell-disease/245870.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/standardization-of-analytical-data-best-practices/246391.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinar-paradigm-shift-in-analytical-development-and-qc/246444.article 2026-04-01T14:37:20.713Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-january-2025/246534.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-approves-sarclisa-for-newly-diagnosed-multiple-myeloma/246626.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/moderna-reports-record-for-uk-clinical-trials-in-2023/24/246638.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/draft-regulatory-guidance-on-personalised-cancer-therapies-published/246893.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-drug-approved-for-diabetes-related-vision-loss/247114.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/unlocking-intellectual-property-potential-in-european-pharma/247140.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/biologic-could-reduce-treatment-burden-for-children-with-haemophilia-a/247497.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-cancels-450m-liverpool-vaccine-facility-expansion/247991.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-nets-potential-first-in-class-medicine-in-new-cardiovascular-acquisition/248200.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-of-a-kind-eu-approval-granted-for-oral-small-molecule/248465.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eu-urban-wastewater-treatment-directive-may-compromise-eu-medicine-availability/248498.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/innovating-bioanalysis-to-advance-oligonucleotide-therapeutics/248515.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/climate-crisis-and-technological-innovation-shaping-pharmaceutical-water-market/248602.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharmaceutical-training-boost-how-the-growth-and-skills-levy-could-shape-industry-development/248785.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/accelerating-process-chemistry/248790.article 2026-03-31T14:12:31.220Z https://www.europeanpharmaceuticalreview.com/news/water-based-reactors-offer-pharmaceutical-industry-a-safer-alternative-to-toxic-solvents/248807.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-nanoparticle-based-technique-could-advance-pharmaceutical-formulations/248850.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/photochemistry-development-aids-peptide-based-therapy-progress/248933.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/stabilising-europes-generic-medicine-supply/248988.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/how-could-tariffs-impact-the-pharmaceutical-industry/248998.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/first-in-human-data-for-gene-therapy-signals-potential-in-childhood-blindness/249089.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-novel-immunotherapy-for-leukaemia/249342.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/greener-method-for-ethylene-oxide-manufacture-identified/249373.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/could-novel-3d-printing-method-enhance-intestinal-drug-delivery/249456.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/imaging-discovery-could-accelerate-drug-development/249461.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/preparing-for-a-new-era-in-the-rare-disease-sector/249567.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-hub-to-drive-manufacturing-innovation-in-scotland/249608.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sustainable-method-converting-waste-into-pharmaceuticals-developed/249790.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-february-2025/249813.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/deepening-digitalization-in-drug-discovery-at-ptc-therapeutics/249896.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/vulnerable-medicine-list-to-aid-us-medicine-supply-resilience/250049.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-1-2025/250121.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/alzheimers-drug-requires-strengthened-pharmacovigilance-approach/250128.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/investigational-plaque-psoriasis-treatments-show-promise-in-late-stage-trials/250331.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bristol-myers-squibb-to-acquire-2seventy-bio/250341.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/msd-bolsters-us-manufacturing-capacity-with-1b-investment/250429.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-innovative-endometriosis-pill/250489.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-commission-approves-rytelo-for-lr-mds-related-anaemia/250594.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/improving-method-transfer-outcomes/250605.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/nanomaterial-research-potential-game-changer-for-drug-delivery/250619.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-cell-therapy-acquisition-to-advance-in-vivo-therapies/250863.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-industry-membership-reinstated/250922.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/psilocybin-therapy-demonstrates-sustained-clinical-benefit-in-treatment-resistant-depression/250990.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/drug-for-rare-form-of-alzheimers-scientifically-promising/251046.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-artificial-intelligence/251105.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/innovating-intelligent-cleanroom-control-systems/251167.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/optimal-biosafety-cabinet-cleaning-strategy-proposed/251360.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/msd-to-advance-investigational-lpa-inhibitor-in-nearly-2b-deal/251380.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-first-in-class-oral-antibiotic/251433.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/tariffs-could-threaten-medicine-innovation-industry-bodies-warn/251443.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-case-for-immigration-concessions-maintaining-the-uks-competitiveness-in-science-and-technology/251491.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/shift-to-automated-and-sustainable-options-shaping-environmental-monitoring-market/251570.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/accurate-and-reproducible-quantitation-of-xc/uv/ms-data-from-any-instrument/251707.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-gains-rights-to-novel-small-molecule-inhibitor/251716.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-framework-could-enhance-process-efficiency-in-manufacturing-quality-control/251749.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ema-proposes-streamlined-approach-for-biosimilar-development/251830.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/ai-in-pharmaceutical-development-hype-or-panacea/251835.article 2026-04-01T11:12:51.837Z https://www.europeanpharmaceuticalreview.com/news/novel-design-proposed-for-aseptic-processing-areas/251890.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-key-role-of-gmp-analytical-testing-for-drug-products/251977.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/prioritise-cultural-change-to-enhance-pharma-digital-innovation-efforts-says-pistoia-alliance/251983.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sampling-system-offers-unique-strategy-for-airborne-bacterial-detection/252179.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsk-to-advance-antibody-medicines-for-neurodegenerative-diseases/252243.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/beyond-instruments-streamlining-process-technology-implementation-in-biopharmaceutical-manufacturing/252259.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/navigating-the-regulatory-challenge-of-pfas-for-pharmaceutical-manufacturers/252337.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/cpi-launches-first-of-a-kind-digitalisation-framework/252348.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-analysis-sets-stage-for-improved-uk-clinical-trials/252384.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/regulating-decentralised-manufacturing-in-the-uk-a-legal-perspective/252389.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-new-combination-breast-cancer-drug/252520.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-approach-could-improve-cancer-immunotherapy/252613.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-eu-guidance-seeks-to-address-radiopharmaceutical-supply-chain-vulnerabilities/252653.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/from-pipettes-to-processors-how-ai-is-reshaping-pharmas-future/252672.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/qbd-for-biopharmaceutical-product-lifecycle-management/252712.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/european-commission-alzheimers-drug-approval-marks-advancement-for-eu-patients/252759.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-drug-delivery-method-for-cell-therapies-reported/252817.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-releases-topline-data-for-new-oral-glp-1/252875.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-novel-therapy-for-chronic-skin-condition/254214.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/antibody-treatment-demonstrates-potential-in-lupus-kidney-disease/254275.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/boehringer-agrees-new-partnership-to-advance-first-in-class-precision-cancer-therapies/254364.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/automated-particle-image-analysis-could-optimise-powder-adhesion-measurement/254396.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/ai-driven-biomanufacturing-revolutionising-production-and-quality-in-pharmaceuticals/254402.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/key-trends-and-technologies-in-drug-delivery-for-2025-and-beyond/254459.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/could-investigational-drug-become-first-in-class-bronchiectasis-therapy/254485.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-april-2025/254643.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/usp-boosts-support-for-aav-based-gene-therapy-manufacturers/254703.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-the-future-of-cell-and-gene-therapy/254714.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-to-lead-oligonucleotide-therapy-development-in-new-collaboration/254766.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-17b-novartis-acquisition-to-advance-novel-microrna-inhibitor/254821.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-first-of-a-kind-gene-therapy-for-dystrophic-epidermolysis-bullosa/254869.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-jandj-data-signals-progress-in-ulcerative-colitis-treatment-landscape/255112.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/improving-eus-regulatory-framework-for-enhanced-pharma-competitiveness/255138.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/landmark-uk-india-trade-deal-insufficient-for-life-sciences-says-industry-body/255219.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/qualification-of-non-mutagenic-impurities-nmis/255289.article 2026-04-02T08:40:47.257Z https://www.europeanpharmaceuticalreview.com/news/tackling-eu-supply-chain-challenges-while-boosting-innovation/255328.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-car-t-therapy-could-deliver-in-broader-therapeutic-settings-research-suggests/255376.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/world-first-approval-supports-astrazenecas-sustainability-goals/255587.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-breast-cancer-treatment-approach-significantly-enhances-survival/255619.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/ai-a-game-changer-in-unifying-clinical-data/255689.article 2026-04-01T08:14:55.890Z https://www.europeanpharmaceuticalreview.com/news/gsk-to-expand-hepatology-pipeline-with-potential-best-in-class-therapy/255690.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/takeda-investigational-drug-shows-efficacy-in-narcolepsy/255806.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-ceo-to-exit-role/255857.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/uk-immigration-reform-implications-for-life-sciences/255870.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/uk-government-commits-to-long-term-randd-funding/256230.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-real-world-data-guidance-could-accelerate-drug-approvals/256283.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-rise-of-multimodal-language-models-in-drug-development/256440.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/biontech-pledges-major-uk-investment/256462.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/measuring-ais-impact-on-the-pharmaceutical-industry/256553.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sanofi-to-enhance-neurology-pipeline-with-new-acquisition/256592.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approval-marks-shift-in-diabetic-retinopathy-treatment/256667.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/major-trial-indicates-potential-of-novel-hypertension-drug/256902.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-may-2025/256936.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-eli-lilly-acquisition-to-progress-potential-next-generation-pain-treatment/257085.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-technology-could-enhance-car-t-therapy-manufacture/257158.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/strategies-for-endotoxin-testing-of-rna-lnp/257300.article 2026-03-19T16:03:56.497Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-environmental-monitoring/257304.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/roche-reports-long-term-capabilities-of-multiple-sclerosis-drug/257387.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/randd-and-tech-innovation-boosting-biopharmaceutical-market-to-2030/257580.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biontech-and-bms-partner-to-advance-oncology-deal-worth-over-10-billion/257653.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-council-announces-progress-on-pharmaceutical-package-adoption/257813.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-issues-first-uk-guidance-on-phage-therapies/257890.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/duchenne-gene-therapy-interim-trial-outcomes-striking/258052.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/engineering-scalable-ipsc-nk-therapies/258063.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/multi-billion-pound-funding-to-accelerate-uks-high-growth-sectors/258342.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/construction-begins-on-new-wuxi-microbial-manufacturing-site/258490.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-grants-expanded-approval-for-hepatitis-drug/258704.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lancet-study-illustrates-drug-delivery-milestone/258773.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-class-2-medicine-recalls-may/june-2025/259005.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-2-2025/259228.article 2026-04-23T15:50:36.970Z https://www.europeanpharmaceuticalreview.com/guide-to-testing-2025/259267.article 2026-04-01T11:46:41.877Z https://www.europeanpharmaceuticalreview.com/reports/bioprocessing-/-bioproduction-in-depth-focus-2025/259272.article 2026-04-17T09:25:00.203Z https://www.europeanpharmaceuticalreview.com/news/ucb-commits-to-major-us-biologics-manufacturing-investment/259350.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/enhancing-chromatographic-protein-purification-with-light/259410.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/streamlining-european-expansion-for-cell-and-gene-therapies/259541.article 2026-04-17T17:08:36.443Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-genetic-medicine-acquisition-to-address-cardiovascular-risk/259595.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/new-biosimilar-pathways-key-takeaways-from-the-emas-draft-reflection-paper/259680.article 2026-03-31T21:32:52.250Z https://www.europeanpharmaceuticalreview.com/news/nice-concludes-decision-for-two-alzheimers-treatments/259701.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-method-could-optimise-beta-blocker-synthesis/259890.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/regulatory-shift-signals-potential-change-for-future-cgt-sector/260300.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/life-sciences-a-priority-sector-in-uk-industrial-strategy/260384.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ipsc-car-nk-cell-therapy-exhibits-autoimmune-potential/260615.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/radioligand-therapy-could-address-multiple-cancer-types/260714.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gilead-partners-to-advance-novel-oral-oncology-drug/260861.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/alliance-for-impact-advancing-cgt-development-in-europe/260878.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/abbvie-immunology-deal-to-advance-potential-first-in-class-therapy/261314.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-pre-filled-autoinjector-receives-eu-approval/261415.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/a-rapid-microbiological-method-case-study-for-advanced-therapy-medicinal-products/261548.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sandoz-breaks-ground-on-new-european-biosimilar-plant/261563.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gene-therapy-could-improve-genetic-deafness/261692.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/next-drug-patent-cliff-to-challenge-big-pharma-strategy/261834.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-first-of-a-kind-oral-therapy-for-rare-disease/262303.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-amgen-data-highlights-promise-in-gastric-cancer/262487.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/supporting-the-pharmaceutical-industry-how-a-cdmo-can-help/262556.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/realising-safer-tuberculosis-treatment-with-novel-antibiotics/262566.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/msd-acquisition-to-accelerate-first-in-class-copd-drug/262736.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/advancing-endotoxin-testing-with-sustainable-recombinant-lal-solutions/262753.article 2026-03-31T15:07:12.360Z https://www.europeanpharmaceuticalreview.com/news/technology-advancement-to-drive-lab-automation-market-through-next-decade/262867.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/updated-licensing-agreement-marks-major-milestone-in-global-hiv-response/263230.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/breaking-down-silos-how-digital-tools-can-transform-pharma-manufacturing/263330.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-innovative-cystic-fibrosis-therapy/263354.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uk-government-publishes-life-sciences-sector-plan/263472.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-leading-edge-formulation/263508.article 2026-04-16T17:18:42.010Z https://www.europeanpharmaceuticalreview.com/news/ai-model-demonstrates-potential-for-streamlining-clinical-trials/263674.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/boehringer-partnership-to-advance-biologic-for-rare-skin-condition/263783.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-approves-needle-free-allergy-drug-alternative/264126.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-16-billion-acquisition-to-advance-respiratory-vaccines/264140.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/world-first-legislation-backs-decentralised-manufacturing/264160.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/stanford-research-illustrates-safer-stem-cell-transplants-for-genetic-disease/264168.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/what-will-shape-the-pharma-landscape-in-q3-2025/264183.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/considerations-for-contact-plate-recovery-in-cleanrooms/264217.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bristol-myers-squibb-names-new-head-of-development/264233.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eu-and-us-agree-preliminary-tariffs-deal/264246.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/extension-trial-demonstrates-long-term-benefit-for-lilly-alzheimers-drug/264279.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/broad-label-fda-approval-for-phenylketonuria-drug/264303.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/scaling-for-the-glp-1-revolution-meeting-global-injectable-demand/264310.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/amid-fda-turmoil-sareptas-gene-therapy-worries-begin-to-ease/264333.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sandoz-acquisition-to-boost-in-house-biosimilar-capabilities/264339.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-abbvie-data-highlights-rinvoq-promise-in-alopecia-areata/264382.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ofichem-acquires-uppsala-site-from-meribel-pharma-solutions/264392.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-accelerates-towards-its-factory-of-the-future-vision/264421.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biowaste-innovation-could-advance-green-pharmaceutical-production/264430.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/ai-act-data-governance-and-compliance-strategy-implications-in-pharma/264445.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/ai-driving-automated-microbiological-testing-market-growth-to-2033/264463.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mrna-vaccine-research-worth-500m-cut-by-rfk-jr/264467.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eu-biotech-act-public-consultation-opens-for-input/264502.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/steady-progress-for-uk-healthcare-manda-in-h1-report-finds/264511.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-to-encourage-new-manufacturing-sites-with-its-precheck-programme/264544.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-to-sell-off-branchburg-site-as-its-us-manufacturing-plans-take-shape/264562.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/vinay-prasad-returns-to-lead-vaccines-and-cell-and-gene-therapy-at-the-fda/264586.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/t-cell-engagers-set-to-drive-immuno-oncology-market/264597.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/tcs-revolutionize-clinical-trial-monitoring-and-data-analysis-with-ar/vr-driven-immersive-analytics/264622.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/novartis-scores-phase-iii-wins-for-two-ianalumab-indications/264626.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bionova-scientific-opens-pdna-facility-in-the-us/264632.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/puretech-taps-ex-teva-ceo-to-run-its-new-respiratory-unit-celea/264646.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/abbvie-invests-195m-to-expand-api-manufacturing-in-the-us/264673.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/trump-executive-order-targets-us-pharma-supply-chain-resilience/264691.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/resilient-supply-reliable-care-safeguarding-europes-generics-in-an-uncertain-world/264692.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/daewoongs-microneedle-patch-marks-semaglutide-first-in-obesity/264704.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofis-tzield-type-1-diabetes-immunotherapy-wins-uk-first/264747.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ich-opens-consultation-on-q3e-drug-impurities-guideline-on-leachables/264749.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nanoscope-gene-therapy-data-signals-potential-retinal-disease-advancement/264809.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/wuxi-biologics-granted-novel-authorisation-for-commercial-biologic-manufacturing-in-ireland/264819.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/csl-to-slash-headcount-by-15-and-spinout-its-csl-seqirus-vaccines-business/264831.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharma-cautious-about-rushing-towards-direct-to-consumer-drug-sales/264833.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mercks-springworks-therapeutics-gains-european-approval-for-ogsiveo/264857.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/boehringer-ingelheim-signs-gene-therapy-manufacturing-deal-with-anges/264863.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/understanding-european-regulatory-requirements-for-low-gwp-propellant-transition/264883.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-neuroscience-executive-anne-white-to-retire/264895.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/johnson-and-johnson-builds-on-us-manufacturing-pledge-with-2bn-fujifilm-investment/264935.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gileads-kite-agrees-350m-deal-to-acquire-us-biotech-interius-biotherapeutics/264938.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uk-yet-to-agree-on-vpag-scheme-following-accelerated-review/264963.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/late-stage-trial-boost-for-argenxs-myasthenia-gravis-drug-vyvgart/264974.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-starts-publishing-daily-adverse-event-data/264977.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharmacopeial-discussion-group-releases-major-particulate-contamination-update/265006.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-decentralised-car-t-manufacturing-consortium-launched/265008.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-pilot-to-prepare-sponsors-for-clinical-trial-regulation-changes/265038.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-tightens-use-of-pfizer-moderna-and-novavax-covid-19-vaccines/265039.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/teva-wins-us-obesity-approval-for-its-glp-1-generic-liraglutide/265067.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ai-digital-twin-developed-to-boost-pharma-manufacturing-efficiency/265069.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chinese-adc-dominance-expected-to-drive-the-first-bispecific-approval/265093.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/roche-touts-best-in-disease-potential-for-anti-hypertensive-zilebesiran/265094.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-waives-trial-requirement-for-stelera-biosimilar-easing-the-copycats-path/265125.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/critical-medicines-act-must-prioritise-eu-pharmaceutical-manufacturing-competitiveness/265132.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mercks-health-business-gains-new-global-head-of-randd/265153.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/demand-for-ai-integration-propelling-mass-spectrometry-growth/265163.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-3-2025/265167.article 2026-03-30T12:35:08.590Z https://www.europeanpharmaceuticalreview.com/microbiology/rmm-in-depth-focus-2025/265182.article 2026-03-31T14:12:31.220Z https://www.europeanpharmaceuticalreview.com/drug-development-in-depth-focus-2025/265184.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/guide-to-outsourcing-2025/265187.article 2026-03-31T15:06:24.440Z https://www.europeanpharmaceuticalreview.com/news/roche-en-route-to-first-continuous-delivery-treatment-for-namd-in-europe/265212.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/amgen-to-build-600m-science-and-innovation-centre-in-the-us/265213.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gilead-breaks-ground-on-ai-enabled-us-manufacturing-hub/265246.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-to-modernise-review-process-for-developers-of-ultra-rare-diseases/265249.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/who-adds-cancer-and-diabetes-drugs-to-its-essential-medicines-list/265277.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/servier-acquires-treatment-for-autism-genetic-cause-fragile-x-syndrome/265279.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-expands-in-cardiovascular-disease-with-14bn-tourmaline-bio-acquisition/265299.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cphi-frankfurt-2025-prepares-to-open-its-doors/265307.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-first-of-a-kind-intravesical-drug-delivery-system-for-bladder-cancer/265326.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/obesity-drug-competition-fuels-novo-nordisk-restructure/265342.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/in-line-pharma-monitoring-system-developed-for-tablet-quality-inspection/265376.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharmas-uk-dissatisfaction-mounts-as-merck-and-co-axes-13bn-expansion/265405.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ich-to-implement-m14-guideline-for-post-marketing-safety-submissions/265407.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/worldwide-clinical-trials-appoints-new-ceo-alistair-macdonald/265425.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-generics-firm-zentiva-sold-in-48bn-private-equity-deal/265437.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-builds-on-monte-rosa-collaboration-with-57-billion-deal/265445.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-picks-virginia-for-the-first-of-its-four-new-us-manufacturing-facilities/265473.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsk-outlines-30bn-five-year-plan-for-randd-and-manufacturing-in-the-us/265477.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/merck-opens-150m-climate-neutral-filter-manufacturing-facility-in-ireland/265515.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/takeda-eyes-sustainable-shipping-with-wind-powered-sea-freight/265522.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/validation-data-for-the-new-mas-100-sirius/265533.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/roche-pays-35bn-for-89bio-and-its-potential-best-in-disease-treatment-mash-drug/265536.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/simplified-raav-lysate-purification-for-complex-analytics-of-upstream-samples/265539.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/cphi-pharma-awards-2025-finalists-announced/265542.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/optimising-moisture-and-odour-management-in-pharmaceutical-packaging/265604.article 2026-03-31T20:51:28.657Z https://www.europeanpharmaceuticalreview.com/news/biogen-wins-european-first-for-depression-drug-zurzuvae/265611.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bayer-breaks-ground-on-german-cell-and-gene-therapy-centre/265628.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisks-once-weekly-diabetes-jab-kyinsu-set-for-european-approval/265705.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/merck-and-co-scores-european-and-us-wins-for-keytruda/265717.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pfizer-acquires-metsera-and-its-glp-1-candidates-in-new-49bn-obesity-play/265745.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bayer-claims-cell-and-gene-therapy-first-in-parkinsons-research/265751.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-to-site-next-us-manufacturing-facility-in-texas/265819.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/merck-looks-to-digital-to-close-discovery-and-biomanufacturing-workflow-gaps/265823.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/the-critical-role-of-cci-in-drug-development-and-manufacturing/265855.article 2026-04-01T08:13:52.957Z https://www.europeanpharmaceuticalreview.com/news/novel-analytical-approach-could-aid-quality-control-during-nitrosamine-analysis/265860.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/one-time-gene-therapy-could-transform-huntingtons-treatment-landscape/265931.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/moderna-opens-uks-first-mrna-vaccine-manufacturing-facility/265953.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-wins-european-alzheimers-approval-for-kisunla-after-regulatory-setbacks/265972.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/trump-upends-drug-import-policy-with-100-percent-tariff-threat/265974.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/navigating-evolving-clinical-and-regulatory-expectations-as-mrna-outgrows-its-vaccine-roots/265983.article 2026-04-01T11:41:06.760Z https://www.europeanpharmaceuticalreview.com/news/genmab-makes-8bn-acquisition-to-boost-late-stage-antibody-therapy-pipeline/266061.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsks-emma-walmsley-to-step-down-as-ceo/266063.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/kai-beckmann-to-take-over-from-belen-garijo-as-merck-ceo/266143.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/jandjs-tremfya-secures-two-paediatric-psoriasis-approvals-from-fda/266147.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/polpharma-biologics-splits-into-biosimilars-and-cdmo-businesses/266191.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/call-for-greater-investment-and-innovation-from-pharma-to-address-rsv/266198.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bassem-saleh-joins-netherlands-cro-julius-clinical-as-its-new-ceo/266267.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/teva-closes-in-on-sale-of-api-business-tapi/266293.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ai-adoption-in-life-science-labs-faces-a-growing-skills-barrier/266302.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/takeda-withdraws-from-clinical-cell-therapy-activities/266415.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/manufacturing-roundup-symbiosis-biograd-abzena-eschbach-and-more/266440.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-topical-formulation-demonstrates-potential-in-peripheral-neuropathy/266694.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-and-daiichis-datroway-gets-phase-iii-breast-cancer-boost/266702.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/merck-and-co-starts-phase-iib-study-of-tulisokibart-in-rheumatoid-arthritis/266817.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cdmo-wheeler-bio-appoints-jay-benson-as-chief-operating-officer/266826.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/boehringers-jascayd-becomes-first-new-ipf-treatment-in-us-for-a-decade/266937.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-outlines-1bn-india-manufacturing-expansion/266972.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/europe-unveils-science-strategy-as-it-looks-to-become-an-ai-continent/267018.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-to-pilot-faster-review-of-generic-drugs-manufactured-in-the-us/267029.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-increases-scope-of-new-us-api-manufacturing-facility-by-500m/267045.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/rovis-injectables-cdmo-rebrands-as-rois-and-acquires-bms-facility/267072.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bristol-myers-squibb-acquires-cell-therapy-biotech-orbital-for-15bn/267087.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-manufacturing-facility-and-clients-hit-by-fda-action/267113.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-doubles-lokelma-production-at-its-texas-facility/267152.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/rois-cdmo/267200.article 2026-03-05T12:58:51.360Z https://www.europeanpharmaceuticalreview.com/why-speed-and-flexibility-matter-now-more-than-ever/267235.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/keytruda-post-surgery-could-halt-return-of-distant-tumours-in-rare-skin-cancer/267239.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/merck-acquires-jsr-life-sciences-chromatography-business/267249.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uv-contamination-control-robot-shows-pharma-cleanroom-promise/267275.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ipsen-strikes-1bn-deal-to-acquire-french-biotech-imcheck-therapeutics/267297.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/phase-iii-data-for-next-gen-green-inhaler-push-gsk-closer-to-net-zero-targets/267315.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/rentschler-biopharma-marks-construction-milestone-at-new-german-buffer-media-facility/267348.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lillys-baricitinib-exhibits-paediatric-potential-in-major-alopecia-areata-study/267360.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-strengthens-neuroscience-pipeline-with-12bn-avidity-acquisition/267405.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ai/ml-investment-strong-as-uk-biotech-weathers-economic-strain/267415.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/alexion-wins-eu-label-expansion-for-kinase-inhibitor-koselugo/267430.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sirolimus-eluting-balloon-offers-potential-paradigm-shift-in-restenosis-treatment/267438.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ensera-talks-integrated-design-to-manufacture-model-at-cphi-frankfurt-2025/267457.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/axplora-talks-reliability-first-investments-to-secure-api-supply/267463.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/taiwan-talks-evidence-driven-tcm-at-cphi-frankfurt/267467.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-ai-factory-to-accelerate-pharmaceutical-manufacturing-and-development/267474.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ai-expert-warns-pharma-industry-artificial-intelligence-is-a-competitor-not-just-a-tool/267491.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cphi-pharma-awards-2025-reward-fujifilm-rezonbio-and-esteve-leaders/267499.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/raman-based-pat-tool-could-advance-continuous-vaccine-manufacturing/267503.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-draft-guidance-on-biosimilars-offers-regulatory-relief/267537.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ai-reshapes-pharma-recruitment-but-skills-gaps-culture-and-bias-temper-gains/267542.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pfizer-and-novo-nordisk-battle-for-obesity-market-dominance/267550.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-set-to-overhaul-the-uks-rare-disease-drug-regulatory-pathway/267591.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cphi-europe-adds-ai-and-tech-zone-for-its-return-to-milan-in-2026/267611.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/hovione-doubles-spray-drying-capacity-with-100m-us-investment-round/267633.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-boosts-oral-glp-1-manufacturing-capability-with-new-netherlands-facility/267644.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-selects-prof-jacob-george-as-its-first-chief-medical-and-scientific-officer/267675.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chiesi-completes-expansion-of-french-metered-dose-inhaler-facility/267677.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/thermally-driven-chemical-reaction-shows-drug-manufacturing-promise/267704.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-bolsters-leadership-team-with-neuroscience-and-immunology-in-mind/267716.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/galapagos-set-for-small-molecule-and-biologics-pivot-after-cell-therapy-exit/267720.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-seals-obesity-deal-as-pfizer-novo-nordisk-battle-for-metsera/267758.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/policy-reform-call-to-secure-europes-antibiotics-supply/267791.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pfizers-metsera-hunger-sees-it-beat-novo-nordisks-obesity-biopharma-offer/267793.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-opens-third-us-radioligand-manufacturing-facility/267819.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/roches-fenebrutinib-shows-best-in-disease-potential-in-multiple-sclerosis/267823.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-names-dr-richard-pazdur-to-replace-george-tidmarsh-as-cder-director/267853.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/could-a-simple-handle-change-your-cleanroom-contamination-risk/267864.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/heatmos-filter-technology-for-depyrogenation-tunnels-innovations-for-extreme-conditions/267866.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-4-2025/267872.article 2026-04-23T15:49:34.557Z https://www.europeanpharmaceuticalreview.com/news/pharmas-sustainability-push-continues-as-merck-signs-renewable-energy-deal/267879.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/genetically-engineered-ipscs-see-clinical-scale-platelet-manufacturing-potential/267898.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/crdmo-bioduro-appoints-yaohui-ji-as-global-president-for-cmc/267899.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-approves-leqembi-iv-maintenance-as-additional-alzheimers-option/267934.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-hits-sarepta-with-liver-warning-labelling-for-its-dmd-drug-elevidys/267978.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/italian-non-profit-set-for-european-gene-therapy-first-in-wiskott-aldrich-syndrome/267986.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/johnson-and-johnson-targets-oncology-portfolio-with-3bn-halda-acquisition/268003.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharmalab-previews-new-conference-tracks-ahead-of-2025-dusseldorf-event/268004.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/internationally-compliant-framework-backs-rabbit-pyrogen-test-alternative/268034.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/moderna-strengthens-us-mrna-manufacturing-capabilities-with-over-140m-investment/268038.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/insmed-wins-first-eu-approval-for-non-cystic-fibrosis-bronchiectasis-treatment/268048.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/medicines-manufacturing-in-the-uk-to-receive-54m-sustainability-boost/268086.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-biosimilar-version-of-jandjs-simponi-approved-in-europe/268092.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biovectra-teams-up-with-revolution-biomanufacturing-in-mrna/268125.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-furthers-us-manufacturing-commitment-with-2bn-maryland-investment/268133.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/dupixent-receives-first-in-decade-eu-approval-in-chronic-spontaneous-urticaria/268153.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/alzheimers-phase-iii-miss-signals-glp-1ra-combination-therapy-potential/268159.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chiesi-gains-pace-on-climate-target-with-new-carbon-minimal-inhaler-data/268196.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-adjusts-manufacturing-strategy-in-switzerland-to-secure-competitiveness/268209.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/life-sciences-responds-to-2025-uk-autumn-budget/268230.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-antibiotic-free-method-could-limit-biofilm-formation/268243.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-commission-calls-for-bio-based-innovation-in-new-eu-bioeconomy-strategy/268269.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bsi-launches-a-world-first-environmental-standard-for-the-pharma-industry/268345.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/abbvies-atogepant-illustrates-migraine-therapy-label-expansion-potential/268367.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uk-first-country-to-secure-zero-tariff-us-pharmaceuticals-deal/268426.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/regeneron-and-tessera-partner-to-develop-gene-therapy-for-aatd/268454.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cder-director-richard-pazdur-to-retire-from-fda/268494.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/jandj-biologic-imaavy-achieves-eu-first-in-generalised-myasthenia-gravis/268515.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-appoints-another-new-cder-director-selecting-dr-tracy-beth-høeg/268588.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bristol-myers-squibb-wins-fifth-us-approval-for-car-t-cell-therapy-breyanzi/268632.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/takeda-expands-its-adc-and-immuno-oncology-pipeline-as-innovent-deal-closes/268636.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-pharmacopoeia-updates-monoclonal-antibody-standards/268787.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/a-careful-calibration-balancing-small-molecule-needs-and-biologic-innovation/268811.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/csl-opens-1bn-australian-vaccine-and-antivenom-manufacturing-facility/268846.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gamida-cell-wins-cell-therapy-first-in-severe-aplastic-anaemia-from-fda/268906.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/impurities-findings-could-enhance-peptide-drug-safety/268943.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pfizer-boosts-its-obesity-plans-with-2bn-glp-1-yaopharma-deal/268992.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-to-establish-third-new-us-manufacturing-facility-in-alabama/269005.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/europe-edges-closer-to-formalising-new-pharma-package-industry-rules/269084.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/thermo-fisher-scientific-expands-its-bioprocessing-capabilities-in-asia/269092.article 2026-04-24T14:05:30.090Z https://www.europeanpharmaceuticalreview.com/literature-as-data-using-large-language-models-to-prioritise-protein-binding-pockets/269107.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/off-the-shelf-dual-antibody-immunotherapy-shows-myeloma-potential/269163.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nanexa-collaboration-to-enhance-modernas-mrna-drug-delivery/269174.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-recommends-cancer-medicines-by-sfl-pharmaceuticals-and-serum-life-science-europe/269334.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ai-discovered-il-17-inhibitor-from-ascletis-pharma-shows-best-in-class-potential/269358.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gaelic-labs-boosts-its-beta-lactam-manufacturing-with-athlone-deal/269445.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-and-daiichis-enhertu-wins-first-in-decade-us-oncology-approval/269465.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bicycle-therapeutics-strikes-uranium-deal-for-sustainable-radiopharmaceuticals/269518.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/europe-makes-progress-in-its-bid-to-tackle-medicine-shortages/269563.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/jandjs-rybrevant-lazcluze-combination-wins-fda-first-in-lung-cancer/269606.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-chromatography-study-shows-downstream-purification-benefits/269634.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chitose-and-fujifilm-biosciences-sign-biopharma-manufacturing-alliance/269663.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/alnylam-invests-250m-to-boost-rnai-manufacturing-in-the-us/269667.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/aaps-national-biotechnology-conference/244920.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/how-a-well-orchestrated-digital-ecosystem-drives-laboratory-efficiency-and-innovations/245159.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/enhancing-manufacturing-with-process-analytical-technology-pat-in-2025/245567.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/optimizing-micronization-and-spray-drying-to-achieve-high-yields-from-clinical-to-commercial/246646.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/pharmalab-congress-2025-advancing-pharmaceutical-quality-and-innovation/248249.article 2026-03-10T09:47:16.797Z https://www.europeanpharmaceuticalreview.com/webinars/fast-tracking-clinical-success-choosing-the-right-fill-and-finish-cdmo/249296.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/interphex/249503.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/safety-reporting-in-clinical-trials-six-core-considerations-for-success/249892.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/advancing-endotoxin-testing-implementing-sustainable-recombinant-lal-solutions/250054.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/aaps-summer-scientific-forum/250279.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/leveraging-early-insights-to-accelerate-the-oral-drug-development-cycle/251369.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/what-does-the-future-hold-for-drug-formulation-in-2026/252470.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/reflections-and-future-opportunities-in-pharmaceutical-microbiology/252477.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/achieving-rapid-microbial-method-validation-with-precise-reference-standard-quantification/254469.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/controlling-impurities-in-pharmaceutical-waters/255542.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/risks-in-pharmaceutical-quality-the-role-of-reference-standards-in-analytical-procedures/255851.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/lipid-formulations-in-softgels-enhancing-bioavailability-and-therapeutic-efficacy/260828.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/harnessing-ai-to-transform-quality-and-manufacturing-in-life-sciences/261411.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/best-practices-for-pupsit-assembly-design-and-operation/264447.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/the-future-of-contamination-control-in-pharma-from-compliance-to-innovation/264663.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/mastering-impurity-profiling-usps-evolving-standards-and-strategies/264876.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/the-future-of-sterility-testing-one-day-results-with-advanced-rt-rt-pcr-technology/265043.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/automating-quality-control-testing-for-radiopharmaceutical-production/266416.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/cphi-frankfurt/266923.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/realising-autonomous-pharmaceutical-operations/268431.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/increasing-the-effectiveness-of-pharma-endotoxin-testing/268580.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/a-four-step-way-out-of-pharma-manufacturings-asset-management-struggles/269095.article 2026-03-29T18:53:27.433Z